Purchase of Imtakt Liquid Chromatography Columns
Closed Pre-Solicitation Posted
- Solicitation number
- 2026-Q-99318
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6630 Chemical Analysis Instruments
- Place of performance
- Atlanta, Georgia 30341, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention intends to award a sole-source purchase order to Herman-Robbins, LLC (dba Imtakt USA) for Imtakt Liquid Chromatography Columns, with capability statements due by August 6, 2026.
The acquisition will be conducted under FAR Part 12.102(a) sole-source authority. The CDC requires replacement Imtakt Unison UK-C-18 and Cadeza HS-C18 liquid chromatography columns, consumable items used in assays that detect and measure antiretroviral drugs in biological specimens. The assays were developed and validated specifically using these column products, and method validation is tied directly to the exact column chemistry used during development. Substituting a different column would alter retention time, resolution, and reproducibility, requiring costly and time-prohibitive revalidation and risking disruption to ongoing antiretroviral drug monitoring where result accuracy and consistency are critical.
Imtakt Unison UK-C-18 and Cadeza HS-C18 columns are proprietary products manufactured by Imtakt Corporation. Imtakt USA, located at 500 SW 116th Ave, Portland, Oregon 97225, is the sole authorized source for these exact columns and the only responsible source capable of supplying the replacement columns needed to maintain the validity and continuity of the program's existing assays. No competitive solicitation will be posted on SAM.gov; one solicitation will be issued only to the identified entity. Responsible sources believing they can meet the requirements are encouraged to submit written capability statements to the Contracting Officer by the closing date; verbal requests will not be accepted.
Notice text
The Center for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) intends to award a sole source purchase order to the Herman-Robbins, LLC (dba Imtakt USA), 500 SW 116th Ave, Portland, OR, 97225 for the purchase of Purchase of Imtakt Liquid Chromatography Columns.
The authority for this sole source acquisition is in accordance with FAR Part 12.102(a).
The program requires replacement Imtakt Unison UK-C-18 and Cadenza HS-C18 liquid chromatography columns, which are consumable items depleted through routine use in assays that detect and measure antiretroviral drugs in biological specimens. These assays were developed and validated specifically using these column products, and method validation for the testing is tied directly to the exact column chemistry used during development; substituting a different column could alter retention time, resolution, and reproducibility, requiring costly and time-prohibitive revalidation and risking disruption to ongoing antiretroviral drug monitoring where result accuracy and consistency are critical. Imtakt Unison UK-C-18 and Cadenza HS-C18 columns are proprietary products manufactured by Imtakt Corporation, and Imtakt USA is the sole authorized source through which these exact columns can be procured; therefore, Imtakt USA is the only responsible source capable of supplying the replacement columns needed to maintain the validity and continuity of the program's existing assays.
As a result of this synopsis, no competitive solicitation will be posted on sam.gov. We will issue only one solicitation to the identified entity. However, responsible sources that believe they can meet these requirements are encouraged to identify themselves and give written notice by providing a capability statement to the Contracting Officer by the closing date of this posting. The Contracting Officer will not respond to verbal request. All requests must be in writing.
A determination by the Government not to compete this proposed action will be based on responses to this notice and are solely within the discretion of the Contracting Officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.
Inquiries shall be sent to Liubov Kriel by email at vyh1@cdc.gov and reference solicitation #2026-Q-97212 on the subject line.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Sole Source a Thermo Orbitrap Fusion Lumos and Thermo RSLCnano UPLC Maintenance Agreement | CDC Office of Acquisition Services | No set-aside | |
| Hidex 600SLe Liquid Scintillation Counter | National Institute on Drug Abuse | No set-aside | |
| Single Purchase of an Agilent 8890 GC System Custom with dual ECD detectors | EPA Region 4 | No set-aside | |
| Notice of Intent to Sole Source – Boston Scientific | NIH Clinical Center | No set-aside | |
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity